- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Dimensions
-
30 cm
- Extent
-
ii, 95 Blätter
- Language
-
Englisch
- Notes
-
Illustrationen, Diagramme
Ruprecht-Karls-Universität Heidelberg, Dissertation, 2022
- Event
-
Veröffentlichung
- (where)
-
Heidelberg
- (when)
-
2022
- Creator
- Contributor
- Table of contents
- Rights
-
Bei diesem Objekt liegt nur das Inhaltsverzeichnis digital vor. Der Zugriff darauf ist unbeschränkt möglich.
- Last update
-
11.03.2025, 12:13 PM CET
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Object type
- Hochschulschrift
Associated
Time of origin
- 2022
Other Objects (12)
Mathematical predictions for brain tumor response to novel therapies validated by in vivo and in vitro experiments
Novel regional therapies for liver tumors
Novel therapies for graft versus host disease with a focus on cell therapies
Tissue specific estrogen action : novel mechanisms, novel ligands, novel therapies
Next-generation in vivo models for improved pancreatic cancer therapies
Development of novel parvovirus-based anticancer therapies
Myeloid corticoid receptors in CNS autoimmunity: Old targets for novel therapies
Novel degradable pseudodendritic oligoamines for in vitro and in vivo gene delivery
Functional characterization of FMNL1 as potential target for novel anti-tumor therapies
Targeted therapies for neurodevelopmental disorders : model systems, disease mechanisms, and novel approaches
Mechanism of resistance to targeted therapies and chemotherapies in vivo and in vitro in B-ALL
Nanomedicine formulations for combination therapies
Mathematical predictions for brain tumor response to novel therapies validated by in vivo and in vitro experiments
Novel regional therapies for liver tumors
Novel therapies for graft versus host disease with a focus on cell therapies
Tissue specific estrogen action : novel mechanisms, novel ligands, novel therapies
Next-generation in vivo models for improved pancreatic cancer therapies
Development of novel parvovirus-based anticancer therapies
Myeloid corticoid receptors in CNS autoimmunity: Old targets for novel therapies
Novel degradable pseudodendritic oligoamines for in vitro and in vivo gene delivery
Functional characterization of FMNL1 as potential target for novel anti-tumor therapies
Targeted therapies for neurodevelopmental disorders : model systems, disease mechanisms, and novel approaches
Mechanism of resistance to targeted therapies and chemotherapies in vivo and in vitro in B-ALL
Nanomedicine formulations for combination therapies
Mathematical predictions for brain tumor response to novel therapies validated by in vivo and in vitro experiments
Novel regional therapies for liver tumors
Novel therapies for graft versus host disease with a focus on cell therapies
Tissue specific estrogen action : novel mechanisms, novel ligands, novel therapies
Next-generation in vivo models for improved pancreatic cancer therapies
Development of novel parvovirus-based anticancer therapies
Myeloid corticoid receptors in CNS autoimmunity: Old targets for novel therapies
Novel degradable pseudodendritic oligoamines for in vitro and in vivo gene delivery
Functional characterization of FMNL1 as potential target for novel anti-tumor therapies
Targeted therapies for neurodevelopmental disorders : model systems, disease mechanisms, and novel approaches
Mechanism of resistance to targeted therapies and chemotherapies in vivo and in vitro in B-ALL